The Effect of an Urban Sanitation Intervention on Child Health (MapSan)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02362932 |
Recruitment Status :
Completed
First Posted : February 13, 2015
Last Update Posted : May 14, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Diarrhea Helminthiasis | Other: Sanitation | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 1866 participants |
Allocation: | Non-Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | A Controlled Before and After Study to Measure the Effect of an Urban Sanitation Intervention on Child Health, in Low-income Neighborhoods of Maputo, Mozambique |
Study Start Date : | February 2015 |
Actual Primary Completion Date : | September 5, 2018 |
Actual Study Completion Date : | September 5, 2018 |

Arm | Intervention/treatment |
---|---|
Experimental: Intervention
Sanitation
|
Other: Sanitation
Shared sanitation |
No Intervention: Control
No sanitation
|
- Combined prevalence of bacterial and protozoan enteric infections [ Time Frame: 12 month follow-up ]As identified via molecular assays on stool samples, we will measure combined prevalence of the following enteric infections: Campylobacter; Clostridium difficile, Toxin A/B; E. coli O157; Enterotoxigenic E. coli (ETEC) LT/ST; Shiga-like toxin producing E. coli (STEC) stx1/stx2; Salmonella; Shigella; Vibrio cholerae; Yersinia enterocolitica; Giardia; Cryptosporidium; and Entamoeba histolytica
- Combined helminth re-infection at 1 year following baseline de-worming [ Time Frame: 12 month follow-up ]Combined prevalence of the following soil-transmitted helminths, as measured in stool samples via the Kato-Katz method: Ascaris spp., Trichuris spp., hookworm
- Combined helminth re-infection at 1 year following baseline de-worming [ Time Frame: 24 month follow-up ]Combined prevalence of the following soil-transmitted helminths, as measured in stool samples via the Kato-Katz method: Ascaris spp., Trichuris spp., hookworm
- Period prevalence (7-day recall) of gastrointestinal illness [ Time Frame: 12 month follow-up ]We will measure caregiver-reported symptoms of gastrointestinal illness, including diarrhea, vomiting, and abdominal pain.
- Period prevalence (7-day recall) of gastrointestinal illness [ Time Frame: 24 month follow-up ]We will measure caregiver-reported symptoms of gastrointestinal illness, including diarrhea, vomiting, and abdominal pain.
- Height-for-age z-score [ Time Frame: 24 month follow-up ]Height, measured by length/height boards, standardised to z-scores against WHO 2009 Child Growth Standards
- Combined prevalence of bacterial and protozoan enteric infections [ Time Frame: 24 month follow-up ]As identified via molecular assays on stool samples, we will measure combined prevalence of the following enteric infections: Campylobacter; Clostridium difficile, Toxin A/B; E. coli O157; Enterotoxigenic E. coli (ETEC) LT/ST; Shiga-like toxin producing E. coli (STEC) stx1/stx2; Salmonella; Shigella; Vibrio cholerae; Yersinia enterocolitica; Giardia; Cryptosporidium; and Entamoeba histolytica

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 29 Days to 48 Months (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Children normally resident in households with access to new shared sanitation (the intervention) as selected by implementing organisation (WSUP) or control children normally resident in households sharing existing shared sanitation within geographically delimited project bounds and meeting WSUP site selection criteria (including number of people served)
Exclusion Criteria:
- Refusal to participate

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02362932
Mozambique | |
Health Research for Development | |
Maputo, Mozambique, Maputo |
Principal Investigator: | Joe Brown, PhD | Georgia Institute of Technology (Georgia Tech) | |
Study Director: | Oliver Cumming, MSc | London School of Hygiene and Tropical Medicine |
Responsible Party: | London School of Hygiene and Tropical Medicine |
ClinicalTrials.gov Identifier: | NCT02362932 |
Other Study ID Numbers: |
8345 |
First Posted: | February 13, 2015 Key Record Dates |
Last Update Posted: | May 14, 2019 |
Last Verified: | August 2018 |
Helminthiasis Diarrhea Signs and Symptoms, Digestive Parasitic Diseases Infections |